Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Feb 29;10(1):26-33.
doi: 10.4244/AIJ-D-23-00005. eCollection 2024 Feb.

Variability in research culture across busy catheterisation labs in the Asia-Pacific region

Manish Narang  1 , Aseem Saxena  1 , Ramneek Kaur  1 , Hanumanthu Reddy Gopa  2 , Nick E J West  3
Affiliations

Variability in research culture across busy catheterisation labs in the Asia-Pacific region

Manish Narang et al. AsiaIntervention. .

Abstract

Background: Information related to research culture in the busy catheterisation (cath) labs across the Asia-Pacific (APAC) region is sparse.

Aims: The aims of this study were to examine the variability in research culture in busy cath labs in the APAC region and to propose a roadmap for hospitals to develop in-house research capabilities in conjunction with industry and academia.

Methods: Data related to research practices in the APAC region were collected from busy cath labs (at least 250 angioplasty/year) and analysed. Results were shared with research experts to understand the challenges in institutional research and create a roadmap for hospitals to develop research capabilities.

Results: A total of 220 respondents from 62 cath labs (88.6%) across 13 APAC countries participated in the survey. A wide variation was noted in research culture across APAC countries. Well-established infrastructure was reported in Australia, New Zealand, South Korea, Singapore, and Japan. Large multicentre trials were common in South Korea, while routine follow-ups were common in Japan. Linking medical records across hospitals/states was considered challenging. Research exposure and training were limited in the APAC region. The experts suggested a roadmap, including creating a conducive regulatory environment, forming synergistic goals, training programs for the professionals involved in research, and leveraging best practices, for improving the research culture in APAC.

Conclusions: Clinical research in cardiology has grown significantly in the APAC region, with a huge research potential in China and India. Implementing measures to improve research training and involvement of the industry will boost the research culture in the APAC region.

PubMed Disclaimer

Conflict of interest statement

M. Narang, A. Saxena, R. Kaur and N.E.J. West are employees of Abbott Vascular. H. Reddy Gopa is an employee of BioQuest Solutions Pvt Ltd.

Figures

Figure 1
Figure 1. Types of studies conducted.
Figure 2
Figure 2. Clinical research infrastructure.
GCP/ICH: Good Clinical Practice/International Council for Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use
Figure 3
Figure 3. Number of peer-reviewed publications/presentations in national/international conferences per year.
Figure 4
Figure 4. Roadmap to bridge gaps in research culture in cath labs in the APAC region.
Central illustration
Central illustration. Illustration of factors contributing to variability and proposed roadmap.
A survey was conducted to assess the variability in research culture in busy catheterisation labs across the Asia-Pacific (APAC) region. The survey outcomes were examined by a group of cardiology experts. The expert discussion resulted in the identification of factors contributing to variability. A roadmap was also proposed for supporting research in APAC settings.
See this image and copyright information in PMC

References

    1. Zhao D. Epidemiological Features of Cardiovascular Disease in Asia. JACC Asia. 2021;1:1–13. - PMC - PubMed
    1. Li JJ, Yeo KK, Tan K, Ako J, Krittayaphong R, Tan RS, Aylward PE, Lam CP, Baek SH, Dalal J, Fong A, Li YH, O’Brien RC, Koh SYN, Scherer DJ, Tada H, Kang V, Butters J, Nicholls SJ. Tackling cardiometabolic risk in the Asia Pacific region. Am J Prev Cardiol. 2020;4:100096. - PMC - PubMed
    1. Gao R. The evolution of percutaneous coronary intervention in Asia: in celebration of the 40th anniversary of percutaneous transluminal coronary angioplasty. AsiaIntervention. 2017;3:95–6.
    1. Glass RI, Razak MH, Said M. The importance of research in the MEPI program: perspectives from the National Institutes of Health. Acad Med. 2014;89:S9–10. - PMC - PubMed
    1. GlobalData Healthcare. Asia-Pacific has seen the largest growth in cardiovascular trials over the past decade. Clinical Trials Arena. 2021. [15 Aug 2023]. https://www.clinicaltrialsarena.com/analysis/cardiovascular-trials-asia-...